ArticleNature communications2026
Automated synthesis of InSb quantum dots with improved batch-to-batch reproducibility via kinetically matched co-reduction.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Automated synthesis of InSb quantum dots with improved batch-to-batch reproducibility via kinetically matched co-reduction.Nature communications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
Indium antimonide (InSb) colloidal quantum dots (CQDs) are attractive heavy-metal-free absorbers for infrared photodetection, yet their synthesis remains challenging because precursor reduction overlaps with nucleation and growth, hindering kinetic control and yielding broad size distributions. Here we employ an automated workflow to achieve precise control over InSb CQD synthesis, leading to improved batch-to-batch reproducibility and narrow size distributions without laborious post-synthetic size-selective precipitation. We find that InSb CQD formation proceeds through a kinetically matched precursor co-reduction pathway, which requires an In-rich environment to compensate for the faster reduction of Sb
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.